Mycrodose Therapeutics

📍 San Diego, United States🗓 Founded 2020👥 4 employees💰 Last funded Mar 2022
Pharmaceutical Manufacturing🌐 mycrodosethera.com
Website LinkedIn
Mycrodose Therapeutics Inc. is a U.S.-based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing DEA Schedule I & III drugs and other compounds to treat cancer related conditions, mental health, and cognitive degenerative diseases. Mycrodoses California laboratory includes a transdermal department with full in-vitro and analytical capacities that allows for all intellectual property and proprietary data to remain in-house. The company believes that its IP-Protected Sustained Microdosing Technology™ is a smarter and safer approach to delivering pharmaceutical compounds to patients of all ages and allows for an expandable and scalable business model.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Mycrodose Therapeutics?
Mycrodose Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Mycrodose Therapeutics last raise funding?
The most recent investment in Mycrodose Therapeutics recorded on gritt.io was in March 2022.
When was Mycrodose Therapeutics founded?
Mycrodose Therapeutics was founded in 2020.
What industry is Mycrodose Therapeutics in?
Mycrodose Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Mycrodose Therapeutics based?
Mycrodose Therapeutics is headquartered in San Diego, United States.